Holland Capital Invests in Curess
Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.
Systemic Family Support
Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.
Strategic Parntership
With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.
Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”
Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”
About Curess
With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.
Walter Balestra shares his experiences on the fast-growing organization ZorgDomein Nederland
Amsterdam, 21st of March 2017 – During the third Holland Venture Growth Session, Walter Balestra (CEO of the fast-growing organization ZorgDomein Nederland) shared his experiences on how his organization acquired a central place in the Dutch healthcare landscape. For...
Holland Venture investeert in semiconductor packaging equipment specialist Boschman Group
Amsterdam/Duiven, 14 maart 2017 - Investeringsmaatschappij Holland Venture investeert in Boschman Group, de specialist in het ontwikkelen van high-end packaging equipment voor de semiconductor industrie. Het groeikapitaal stelt Boschman in staat haar unieke, zelf...
Holland Venture invests in semiconductor packaging equipment specialist Boschman Group
Amsterdam/Duiven, March 14th, 2017 – Holland Venture, a Dutch based investment firm, announced today that it completed an investment in the Boschman Group, a specialist in high-end packaging equipment for the semiconductor industry. This investment enables the...
Holland Venture investeert in de Mauritsklinieken; een keten van klinieken gespecialiseerd in zorg voor de huid
Amsterdam, 9 maart 2017 – Investeringsmaatschappij Holland Venture investeert samen met het management in de Mauritsklinieken, een keten van klinieken gespecialiseerd in zorg voor de huid. Als onderdeel van de transactie worden aandelen overgenomen van de oprichters...
QSight IT versterkt positie met InSpark Inovativ en Sparked gaan samen verder als InSpark
Amsterdam, 7 maart 2017 – De cloud consultancybureaus en Microsoft Gold Partners inovativ en Sparked bundelen de krachten om digitale transformatie bij klanten nóg beter vorm te geven. De nieuwe organisatie gaat verder onder de naam InSpark.Innovate to...
QSight IT strengthens position with InSpark
Inovativ and Sparked are continuing as InSpark Amsterdam, 7 March 2017 – cloud consultancy agencies and Microsoft Gold Partners inovativ and Sparked have joined forces and are continuing as InSpark. InSpark provides a higher level of innovation to customers and...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl